Alexander von Gabain

Last updated

Alexander von Gabain is a microbiologist, academic, founder of several biotech firms and board member of venture capital firms. He has worked at the intersection of the healthcare industry, academia and research throughout his career. He was one of the founding board members of EIT in 2008 [1] and began his involvement in EIT Health in 2015. [2]

Contents

His passion for biomedical research and innovation, particularly in the fields of microbiology, immunology and vaccines, has been well-documented through numerous publications; [3] and his achievements in these fields have been well-recognised through industrial awards, academic prizes and honourable memberships.

Academic background

von Gabain obtained his PhD in Genetics at the University of Heidelberg and held a post-doctorate position at Stanford University from 1979 to 1982. [4]

In the 1980s and 1990s, he was Professor at the University of Umeå and at the Karolinska Institute in Stockholm, Sweden, as well as an advisor to pharmaceutical and biotech companies. From 1993 to 1999, he was chair of Microbiology of the University of Vienna and engaged in building the public-private partnership between the Vienna-based universities and Boehringer Ingelheim known as Vienna Biocenter. [4]

His current academic appointments include as a member of the Scientific Advisory Board of the Paul Ehrlich Institute, [5] a member of the Board of Trustees of the Institute of Science and Technology Austria (ISTA), [6] a member of the Royal Swedish Academy of Engineering Sciences [7] and a Professor Emeritus for Microbiology at the Max F. Perutz Laboratories, a center established by the University of Vienna and the Medical University of Vienna. [8] He also serves as Vice-President Emeritus at the Karolinska Institute in Stockholm, [4] having served as Deputy Vice-Chancellor for Innovation and Commercial Outreach between 2014 and 2017. [9]

Intercell and other innovation work

von Gabain co-founded Intercell AG in 1998, led the company until it was successfully floated on the Vienna Stock Exchange in 2005[ [10] 1] and continued as Chief Scientific Officer in the Executive Board until 2009. [11] In 2011, he was appointed to the company's Supervisory Board [12] and continues to hold this position after it Intercell and Vivalis merged into the trans-European biotech enterprise, Valneva, listed on Euronext Paris since 2013 [13] and on Nasdaq since 2021. [14] Valneva has today two global vaccines on the market, more than 600 employees and three major vaccines in late clinical development.

Additionally, he has supported other biotech enterprises and related VC firms in various functions. His entrepreneurial and scientific knowledge in the innovation arena has been highly sought after by organisations fostering entrepreneurial innovation. Between 2007 and 2019, he was Chair of INiTS, the technology seed fund and incubator of the University of Vienna and the Technical University of Vienna, [15] initiating more than 300 start-ups and ranking amongst the top ten of university incubators globally. [16] He is currently a member of the Supervisory Board of Eveliqure- an innovative biotech company developing novel vaccines for the prevention of diarrhoeal disease, [17] a member of the Supervisory Board of Biocopy- whose patented biomolecule copier is used for the production and replication of all kinds of different microarrays. [18]

EIT and EIT Health

In 2008, he was appointed as a founding member of the Governing Board of the European Institute of Innovation and Technology (EIT) [1] and in 2011 was elected to become its Chairman for a period ending in 2014. [4] [19] During this time, the first three of EIT's Knowledge and Innovation Communities (KICs) were established and EIT evolved into a multi-billion dollar organisation.

In 2015, he joined the Supervisory Board of EIT Health [20] - an innovation consortium with more than 150 leading organisations and institutions from the European healthcare space. [4] In 2017, he was appointed Chair of the organisations Supervisory Board, [21] a position he held until 2021. [22]

Related Research Articles

<span class="mw-page-title-main">Karolinska Institute</span> Medical university located in Stockholm, Sweden

The Karolinska Institute is a research-led medical university in Solna within the Stockholm urban area of Sweden and one of the foremost medical research institutes globally. The Nobel Assembly at the Karolinska Institute awards the Nobel Prize in Physiology or Medicine. The assembly consists of fifty professors from various medical disciplines at the university. The current vice-chancellor of Karolinska Institute is Annika Östman Wernerson, who took office in March 2023.

<span class="mw-page-title-main">Gustav Nossal</span> Australian research biologist (born 1931)

Sir Gustav Victor Joseph Nossal is an Austrian-born Australian research biologist. He is famous for his contributions to the fields of antibody formation and immunological tolerance.

The European Institute of Innovation and Technology (EIT) is an independent body of the European Union with juridical personality, established in 2008 intended to strengthen Europe's ability to innovate. The EIT’s three “core pillars” of activities are: entrepreneurial education programmes and courses across Europe that transform students into entrepreneurs; business creation and acceleration services that scale ideas and budding businesses; and innovation-driven research projects that turn ideas into products by connecting partners, investors, and expertise.

Thomas Eugene Shenk is an American virologist. He is currently Emeritus Professor of Life Sciences in the Department of Molecular Biology at Princeton University.

<span class="mw-page-title-main">Linnar Viik</span> Estonian information scientist and scholar

Linnar Viik is an Estonian information technology scientist, entrepreneur and IT visionary.

<span class="mw-page-title-main">Patrick Soon-Shiong</span> South African billionaire physician, CEO & philanthropist (b. 1952)

Patrick Soon-Shiong is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

<span class="mw-page-title-main">Intercell</span> Defunct biotechnology company in Austria

Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna. It employs 400 people in Austria, Scotland and the United States.

The International Vaccine Institute (IVI) is a non-profit, autonomous international organization established with the mandate of making vaccines available for all. Collaborating closely with the global scientific community, public health entities, governments, and industry stakeholders, IVI focuses on vaccine research and deployment. This includes conducting new vaccine designs in laboratories, advancing vaccine development and assessment in real-world settings, and facilitating the sustainable integration of vaccines in regions where they are most urgently required.

<span class="mw-page-title-main">Austrian Institute of Economic Research</span>

The Austrian Institute of Economic Research is a private non-profit association located in Vienna, Austria.

<span class="mw-page-title-main">Max Birnstiel</span> Swiss molecular biologist (1933–2014)

Max Luciano Birnstiel was a Swiss molecular biologist who held a number of positions in scientific leadership in Europe, including the chair of the Institute of Molecular Biology at the University of Zurich from 1972–86, and that of founding director of the Research Institute of Molecular Pathology (IMP) in Vienna from 1986 to 1996. His research focused on gene regulation in eukaryotes. His research group is sometimes cited as the first to purify single genes, the ribosomal RNA genes from Xenopus laevis, three years before the successful isolation of the lac operon. He is also recognized for one of the earliest discoveries of a gene enhancer element. Birnstiel died in 2014 of heart failure during cancer treatment.

Gagandeep Kang FRS is an Indian microbiologist and virologist who has been leading the work on enteric diseases, diarrheal infections and disease surveillance at the Bill & Melinda Gates Foundation since 2023.

<span class="mw-page-title-main">Coalition for Epidemic Preparedness Innovations</span> Public-private organization for vaccine development

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

Brahm Shanker Srivastava is an Indian microbiologist, inventor and a former deputy director and head of Microbiology division of the Central Drug Research Institute. He is the founder of Biotech Research, a non-profit non governmental institution promoting research in the field of biotechnology and is a director of Nextec Lifesciences Private Limited, a start up involved in biomedical products and research applications. He is known for his researches on microbial genetics and is an elected fellow of the National Academy of Sciences, India.

Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.

<span class="mw-page-title-main">Rick Bright</span> American immunologist and whisteblower

Rick Arthur Bright is an American immunologist, vaccine researcher, and public health official. He was the director of the Biomedical Advanced Research and Development Authority (BARDA) from 2016 to 2020. In May 2020, he filed a whistleblower complaint, alleging that the Trump administration ignored his early warnings about the COVID-19 pandemic and illegally retaliated against him by ousting him from his role and demoting him to a position at the National Institutes of Health. On October 6, 2020, Bright resigned from the government. On November 9 he was named a member of President-elect Joe Biden's coronavirus advisory board.

<span class="mw-page-title-main">Moncef Slaoui</span> Moroccan-American-Belgian doctor and researcher

Moncef Mohamed Slaoui is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.

<span class="mw-page-title-main">Michelle McMurry-Heath</span> American Immunologist

Michelle McMurry-Heath is a medical doctor, immunologist, and from June 2020 until October 2022 served as chief executive officer for the Biotechnology Innovation Organization (BIO).

<span class="mw-page-title-main">Valneva COVID-19 vaccine</span> Vaccine candidate against COVID-19

Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies.

<span class="mw-page-title-main">Drew Weissman</span> American physician and immunologist (born 1959)

Drew Weissman is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).

BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.

References

  1. 1 2 "Official appointment of the EIT Governing Board: the European Institute of Innovation and Technology set for an Autumn launch in Budapest". Archived from the original on 2020-10-25.
  2. ↑ "Science Business". Archived from the original on 2017-10-19.
  3. ↑ "von Gabain a - Search Results - PubMed". PubMed. Retrieved 2021-12-20.
  4. 1 2 3 4 5 "CV from EIT Health" (PDF). Archived (PDF) from the original on 2020-12-31.
  5. ↑ "Scientific Advisory Board of Paul-Ehrlich Institute" (PDF). Archived (PDF) from the original on 2021-04-20.
  6. ↑ "Board of Trustees of IST Austria". Archived from the original on 2020-05-04.
  7. ↑ "International Fellows of the Royal Swedish Academy of Engineering Sciences". Archived from the original on 2020-09-25.
  8. ↑ "RsearchGate.net Profile". Archived from the original on 2021-12-20.
  9. ↑ "Karolinska Institutet News Article". Archived from the original on 2021-12-20.
  10. ↑ "Life Science Austria - Vienna Region's Newsletter" (PDF). January 2005. Archived (PDF) from the original on 2019-10-15.
  11. ↑ "Intercell Geschäftsbericht 2009v". April 2010. Archived from the original on 2010-05-06.
  12. ↑ "Intercell Press Release". 5 May 2011. Archived from the original on 2020-08-15.
  13. ↑ "Valneva Press Information" (PDF). Archived (PDF) from the original on 2021-12-20.
  14. ↑ "Valneva Press Release". Archived from the original on 2021-05-06.
  15. ↑ "INiTS Universitäres Gründerservice Wien congratulates Sabine Seidler, Heinz Engl and Alexander von Gabain". Archived from the original on 2021-12-20.
  16. ↑ "Wiener INiTS in den Top 10 der Uni-Inkubatoren". 27 November 2015. Archived from the original on 2021-12-20.
  17. ↑ "Eveliqure Board". Archived from the original on 2020-08-07.
  18. ↑ "BioCopy AG". Archived from the original on 2020-08-15.
  19. ↑ "Alexander von Gabain starts as Chairman of the EIT Governing Board". 14 September 2011. Archived from the original on 2019-06-15.
  20. ↑ "Home". eithealth.eu.
  21. ↑ "EIT Health appoints Alexander von Gabain Supervisory Board Chairman". Archived from the original on 2017-10-19.
  22. ↑ "EIT Health announces new Supervisory Board". Archived from the original on 2021-09-28.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.